FREE CANADA-WIDE EXPRESS SHIPPING ON ORDERS OVER $350
Reviews transferred over to Yotpo (over 140 reviews)
🍁 Owned and operated by a CF Veteran 🇨🇦
FREE Pfizer BW on Purchases over $500: blackdragon, 10% off: peptide party
SALE IN EFFECT, NEUROTROPIN GH 100iu $250 (while quantities last)
Pfizer bac water – In stock New Batch of G-H coming. RESTOCKED – Please double-check junk mail for emails
$269.99 Original price was: $269.99.$150.00Current price is: $150.00.
Research use only; Not for human or veterinary administration. This content is not a substitute for medical advice.
SLU-PP-332 is a small-molecule pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ). This listing is the 20mg research format. It is not a peptide and does not reconstitute in water. This Canadian product listing concerns laboratory research material only. It is not an authorized medicine, does not provide dosing or administration instructions, and is not intended for human or veterinary use.
This listing supplies SLU-PP-332 in a 20mg research quantity for qualified laboratory use in Canada, with published analytical information and domestic express fulfilment. The compound is sourced through Peptide Factory Canada.
For the full mechanism, receptor background and specification detail, see the main SLU-PP-332 research page. This page covers what is specific to working with the larger format.
Red Leaf Research Labs supplies research material to qualified purchasers in Canada. Nothing on this page describes a therapy, a treatment or a permitted personal use.
| Attribute | Detail |
|---|---|
| Research format | SLU-PP-332, 20mg |
| Compound class | Small molecule — not a peptide |
| Molecular formula | C18H14N2O2 |
| CAS number | 303760-60-3 |
| Research target | ERRα, ERRβ, ERRγ — pan-agonist, strongest at ERRα |
| Reconstitution | Co-solvent system required; not water-soluble |
| Sourcing | Peptide Factory Canada |
| Intended use | Qualified laboratory research only |
The difference between a 5mg and a 20mg quantity of SLU-PP-332 is not simply four times the material, because this compound does not dissolve in water.
SLU-PP-332 requires an organic co-solvent — typically DMSO — before dilution into an aqueous working solution. At 20mg, the stock concentration a laboratory chooses determines how much organic solvent ends up in the final assay, and residual solvent is a variable that has to be controlled rather than tolerated. Working from a larger quantity therefore means deciding the stock strategy first: one concentrated stock with careful aliquoting, or several smaller preparations.
Repeated freeze-thaw cycling of a DMSO stock also introduces moisture, which is a well-known failure mode for hygroscopic solvent systems. A laboratory buying the larger format should plan aliquoting at the point of first preparation rather than returning to a single vial repeatedly.
The larger format suits work that is already scoped: an established solvent system, a defined assay, and enough planned runs to consume the material within a sensible window. It is the wrong choice for a first pass at an unfamiliar compound, where a smaller quantity lets a laboratory validate its solubility and handling procedure before committing.
Both formats are the same compound with the same analytical requirements. The choice is about scale of use and shelf time, not about grade.
This 20mg format is sourced through Peptide Factory Canada. Whatever the supply route, the verification steps a laboratory should take are identical: read the analytical report before ordering, confirm it identifies SLU-PP-332 with CAS 303760-60-3, check the lot reference and test date against current product information, and confirm the report can be checked against the issuing laboratory.
For a small molecule, expect chromatographic purity with a mass-based identity confirmation rather than the peptide-mapping methods used on the rest of this catalogue. Where a study design is solvent-sensitive, check whether residual solvents were assessed.
Domestic supply shortens transit, reduces handling stages, and avoids customs detention that can leave material in uncontrolled conditions. It also means the purchaser has a Canadian counterparty when a lot reference does not match or documentation is missing.
None of that substitutes for the buyer’s own verification. Domestic fulfilment is a logistics advantage, not a quality claim.
SLU-PP-332 holds no marketing authorization in Canada or anywhere else. It has not entered human clinical trials and has not been assessed for consumer safety or effectiveness by any regulator. The “exercise mimetic” framing that circulates around this compound comes from rodent exercise-capacity findings and describes results in mouse models, not established properties in people.
Research supply and public availability are separate categories. Material available to a qualified laboratory is not an approved product, a supplement, or a substitute for professional care.
| Check | What to confirm |
|---|---|
| Purpose | Authorized laboratory research with an approved study plan |
| Format fit | 20mg suits the planned run count and shelf window |
| Identity | SLU-PP-332, CAS 303760-60-3, formula C18H14N2O2 |
| Solvent plan | Stock concentration and aliquoting decided before preparation |
| Residual solvent | Assessed where the assay is solvent-sensitive |
| Verification | Report can be checked against the issuing laboratory |
| Handling | Storage and preparation procedures validated by the receiving institution |
Full receptor background, specifications and research context are on the main SLU-PP-332 page. For supplier-selection criteria in the Canadian market, review how to evaluate a Canadian research peptide supplier.
Only in quantity. It is the same compound with the same analytical requirements; the practical difference is that a larger quantity requires a stock-preparation and aliquoting plan decided in advance.
No. SLU-PP-332 is poorly water-soluble and requires an organic co-solvent before dilution into aqueous working solution.
The smaller one, if the solvent system and assay are not yet validated. The 20mg format suits work that is already scoped.
No. It is a small heterocyclic molecule of about 290 daltons containing no peptide bonds.
No. Red Leaf Research Labs supplies research material and analytical documentation only.
Research use only. SLU-PP-332 supplied by Red Leaf Research Labs is intended for qualified laboratory research. It is not a medicine, not for human or veterinary use, and not for diagnostic or therapeutic application.
Third-party tested purity
Ultra high synthesis purity
Temperature controlled logistics
Trusted by researchers worldwide
This product is supplied in a lyophilized powder form to preserve its stability, purity, and potency.
For laboratory research purposes only. Not intended for human consumption.

You must be 18 or 19 years of age depending on the age of majority in your province and a licensed research professional
All products are sold in powder (lyophilized) form and require reconstitution with a suitable diluent for research purposes only. No dosing instructions are provided. We adhere to all provincial and federal laws in Canada around Research Only Chemical sales. We are not a pharmacy and/or compounding facility, nor do we promote or provide any advice for human or animal consumption.
By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above